phosphoserine has been researched along with Scleroderma, Systemic in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, H | 1 |
| Krolikowski, JG | 1 |
| Jones, DW | 1 |
| Ge, ZD | 1 |
| Pagel, PS | 1 |
| Pritchard, KA | 1 |
| Weihrauch, D | 1 |
1 other study available for phosphoserine and Scleroderma, Systemic
| Article | Year |
|---|---|
4F decreases IRF5 expression and activation in hearts of tight skin mice.
Topics: Animals; Apolipoprotein A-I; Apoptosis; Disease Models, Animal; Echocardiography; Endothelial Cells; | 2012 |